Epigenetics of Cardiomyopathy: Histone Modifications and DNA Methylation
- Авторлар: Kucher A.1, Nazarenko M.1
-
Мекемелер:
- Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences
- Шығарылым: Том 59, № 3 (2023)
- Беттер: 266-282
- Бөлім: ОБЗОРНЫЕ И ТЕОРЕТИЧЕСКИЕ СТАТЬИ
- URL: https://journals.rcsi.science/0016-6758/article/view/134564
- DOI: https://doi.org/10.31857/S0016675823030086
- EDN: https://elibrary.ru/IPXZDH
- ID: 134564
Дәйексөз келтіру
Аннотация
Cardiomyopathy is clinically and genetically heterogeneous group of pathologies of myocardium that are being actively studied by researchers. It is now generally accepted that, along with genetic factors, epigenetic mechanisms can be significant in both risk for cardiomyopathy and different clinical manifestations of the disease. This article provides an overview of scientific publications devoted to the study of histone modifications and chromatin remodeling, as well as DNA methylation changes in different types of cardiomyopathy. Most of the reports focused on epigenome profiling of myocardium of patients with dilated cardiomyopathy. The development of cardiomyopathy (dilated, hypertrophic, ischemic, arrhythmogenic, and restrictive) is associated with epigenetic changes of myocardium and this leads to gene expression alteration and metabolic pathways imbalance with pathogenetic significance for heart diseases. The genes of cardiomyopathies (LMNA, TNNI3, ANKRD1, SLC25A4, EYA4, GATAD1, PRDM16, and DMD) are also involved in epigenetic changes of myocardium. Epigenetic modifications, and enzymes that regulate epigenetic processes, are promising for the identification of new molecular markers and metabolic pathways significant for cardiomyopathies, as well as for the development of diagnostic panels and new drugs. At the same time, the high clinical and etiological heterogeneity of cardiomyopathies, a large number of diverse and interrelated epigenetic processes that occur both under physiological conditions and during the pathogenesis of the disease indicate the need to expand epigenetic studies in various forms of cardiomyopathies, including epigenome, transcriptome, and epitranscriptome levels using omics analysis of single cells of myocardium in humans and model animals, as well as in cell lines in disease modeling.
Негізгі сөздер
Авторлар туралы
A. Kucher
Research Institute of Medical Genetics, Tomsk National ResearchMedical Center of the Russian Academy of Sciences
Email: maria.nazarenko@medgenetics.ru
Russia, 634050, Tomsk
M. Nazarenko
Research Institute of Medical Genetics, Tomsk National ResearchMedical Center of the Russian Academy of Sciences
Хат алмасуға жауапты Автор.
Email: maria.nazarenko@medgenetics.ru
Russia, 634050, Tomsk
Әдебиет тізімі
- Jimenez J., Rentschler S.L. Transcriptional and epigenetic regulation of cardiac electrophysiology // Pediatr. Cardiol. 2019. V. 40. № 7. P. 1325–1330. https://doi.org/10.1007/s00246-019-02160-w
- Yu J., Zeng C., Wang Y. Epigenetics in dilated cardiomyopathy // Curr. Opin. Cardiol. 2019. V. 34. № 3. P. 260–269. https://doi.org/10.1097/HCO.0000000000000616
- Schiano C., Benincasa G., Franzese M. et al. Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases // Pharmacol. Ther. 2020. V. 210. P. 107514. https://doi.org/10.1016/j.pharmthera.2020.107514
- Napoli C., Coscioni E., de Nigris F., Donatelli F. Emergent expansion of clinical epigenetics in patients with cardiovascular diseases // Curr. Opin. Cardiol. 2021. V. 36. № 3. P. 295–300. https://doi.org/10.1097/HCO.0000000000000843
- Han P., Li W., Yang J. et al. Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts // Biochim. Biophys. Acta. 2016. V. 1863. № 7. Pt. B. P. 1772–1781. https://doi.org/10.1016/j.bbamcr.2016.03.002
- De Majo F., Calore M. Chromatin remodelling and epigenetic state regulation by non-coding RNAs in the diseased heart // Noncoding RNA Res. 2018. V. 3. № 1. P. 20–28. https://doi.org/10.1016/j.ncrna.2018.02.003
- Zhou Q., Yu B., Anderson C. et al. LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus // Elife. 2019. V. 8. P. e40470. https://doi.org/10.7554/eLife.40470
- Yu J., Yang Y., Xu Z. et al. Long Noncoding RNA ahit protects against cardiac hypertrophy through SUZ12 (Suppressor of Zeste 12 Protein Homolog)-mediated downregulation of MEF2A (Myocyte Enhancer Factor 2A) // Circ. Heart Fail. 2020. V. 13. № 1. P. e006525. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006525
- Pei J., Schuldt M., Nagyova E. et al. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations // Clin. Epigenetics. 2021. V. 13. № 1. P. 61. https://doi.org/10.1186/s13148-021-01043-3
- Ghosh A.K. p300 in cardiac development and accelerated cardiac aging // Aging Dis. 2020. V. 11. № 4. P. 916–926. https://doi.org/10.14336/AD.2020.0401
- Salemi V.M.C., Mohty D., Altavila S.L.L. et al. Insights into the classification of cardiomyopathies: past, present, and future directions // Clinics (Sao Paulo). 2021. V. 76. P. e2808. https://doi.org/10.6061/clinics/2021/e2808
- McKenna W.J., Maron B.J., Thiene G. Classification, epidemiology, and global burden of cardiomyopathies // Circ. Res. 2017. V. 121. № 7. P. 722–730. https://doi.org/10.1161/CIRCRESAHA.117.309711
- МКБ-11 (Международная классификация болезней 11-го пересмотра). [Electronic resource]. URL: https://icd11.ru/ Accessed 03.2022.
- Bhandari B., Quintanilla Rodriguez B.S., Masood W. Ischemic Cardiomyopathy. 2021. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2022.
- Arbustini E., Narula N., Tavazzi L. et al. The MOGE(S) classification of cardiomyopathy for clinicians // J. Am. Coll. Cardiol. 2014. V. 64. № 3. P. 304–318. https://doi.org/10.1016/j.jacc.2014.05.027
- Menon S.C., Michels V.V., Pellikka P.A. et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology // Clin. Genet. 2008. V. 74. № 5. P. 445–454. https://doi.org/10.1111/j.1399-0004.2008.01062.x
- Webber S.A., Lipshultz S.E., Sleeper L.A. et al. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: A report from the Pediatric Cardiomyopathy Registry // Circulation. 2012. V. 126. № 10. P. 1237–1244. https://doi.org/10.1161/CIRCULATIONAHA.112.10-4638
- Lipshultz S.E., Orav E.J., Wilkinson J.D. et al. Wilkinson J.D. et al. Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: An analysis of data from the Pediatric Cardiomyopathy Registry // Lancet. 2013. V. 382. № 9908. P. 1889–1897. https://doi.org/10.1016/S0140-6736(13)61685-2
- Jefferies J.L., Wilkinson J.D., Sleeper L.A. et al. Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction: Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction: Results from the Pediatric Cardiomyopathy Registry // J. Card. Fail. 2015. V. 21. № 11. P. 877–884. https://doi.org/10.1016/j.cardfail.2015.06.381
- Lee T.M., Hsu D.T., Kantor P. et al. Pediatric cardiomyopathies // Circ. Res. 2017. V. 121. № 7. P. 855–873. https://doi.org/10.1161/CIRCRESAHA.116.309386
- Pérez-Palma E., Gramm M., Nürnberg P. et al. Simple ClinVar: An interactive web server to explore and retrieve gene and disease variants aggregated in ClinVar database // Nucl. Acids Res. 2019. V. 47. № W1. P. W99–W105. https://doi.org/10.1093/nar/gkz411
- Комиссарова С.М., Ринейская Н.М., Чакова Н.Н., Ниязова С.С. Смешанный фенотип: некомпактный миокард левого желудочка и гипертрофическая кардиомиопатия // Кардиология. 2020. Т. 60. № 4. С. 137–145. https://doi.org/10.18087/cardio.2020.4.n728
- Blagova O., Alieva I., Kogan E. et al. Mixed hypertrophic and dilated phenotype of cardiomyopathy in a patient with homozygous in-frame deletion in the MyBPC3 gene treated as myocarditis for a long time // Front. Pharmacol. 2020. V. 11. P. 579450. https://doi.org/10.3389/fphar.2020.579450
- Cipriani A., Perazzolo Marra M., Bariani R. et al. Differential diagnosis of arrhythmogenic cardiomyopathy: Phenocopies versus disease variants // Minerva Med. 2021. V. 112. № 2. P. 269–280. https://doi.org/10.23736/S0026-4806.20.06782-8
- Mattesi G., Cipriani A., Bauce B. et al. Arrhythmogenic left ventricular cardiomyopathy: Genotype-phenotype correlations and new diagnostic criteria // J. Clin. Med. 2021. V. 10. № 10. P. 2212. https://doi.org/10.3390/jcm10102212
- Wang J., Li W., Han Y., Chen Y. Different clinical presentation and tissue characterization in a monozygotic twin pair with MYH7 mutation-related hypertrophic cardiomyopathy // Int. Heart J. 2019. V. 60. № 2. P. 477–481. https://doi.org/10.1536/ihj.18-167
- Frade A.F., Laugier L., Ferreira L.R. et al. Myocardial infarction-associated transcript, a long noncoding RNA, is overexpressed during dilated cardiomyopathy due to chronic Chagas disease // J. Infect. Dis. 2016. V. 214. № 1. P. 161–165. https://doi.org/10.1093/infdis/jiw095
- Mazurek S., Kim G.H. Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy // Biochim. Biophys. Acta Mol. Basis Dis. 2017. V. 863. № 8. P. 2064–2069. https://doi.org/10.1016/j.bbadis.2017.04.020
- Mansueto G., Benincasa G., Della Mura N. et al. Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRNAs // J. Clin. Pathol. 2020. V. 73. № 9. P. 535–543. https://doi.org/10.1136/jclinpath-2019-206404
- Calderon-Dominguez M., Belmonte T., Quezada-Feijoo M. et al. Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology // Transl. Res. 2020. V. 215. P. 86–101. https://doi.org/10.1016/j.trsl.2019.08.007
- Pagiatakis C., Di Mauro V. The emerging role of epigenetics in therapeutic targeting of cardiomyopathies // Int. J. Mol. Sci. 2021. V. 22. № 16. P. 8721. https://doi.org/10.3390/ijms22168721
- Ke X., Lin Z., Ye Z. et al. Histone deacetylases in the pathogenesis of diabetic cardiomyopathy // Front. Endocrinol. (Lausanne). 2021. V. 12. P. 679655. https://doi.org/10.3389/fendo.2021.679655
- Mittal A., Garg R., Bahl A., Khullar M. Molecular mechanisms and epigenetic regulation in diabetic cardiomyopathy // Front. Cardiovasc. Med. 2021. V. 8. P. 725532. https://doi.org/10.3389/fcvm.2021.725532
- Scolari F.L., Faganello L.S., Garbin H.I. et al. A systematic review of microRNAs in patients with hypertrophic cardiomyopathy // Int. J. Cardiol. 2021. V. 327. P. 146–154. https://doi.org/10.1016/j.ijcard.2020.11.004
- Guo Y., Feng X., Wang D. et al. Long non-coding RNA: A key regulator in the pathogenesis of diabetic cardiomyopathy // Front. Cardiovasc. Med. 2021 V. 8. P. 655598. https://doi.org/10.3389/fcvm.2021.655598
- Ntelios D., Georgiou E., Alexouda S. et al. A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: The case of hypertrophic cardiomyopathy // Heart Fail. Rev. 2022. V. 27. № 1. P. 281–294. https://doi.org/10.1007/s10741-021-10084-y
- ClinGen [Electronic resource]. URL: https://clinicalgenome.org/ Accessed 03.2022.
- UniProt [Electronic resource]. URL: https://www.uniprot.org/ Accessed 03.2022.
- Gherardi S., Bovolenta M., Passarelli C. et al. Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expression // Biochim. Biophys. Acta Gene Regul. Mech. 2017. V. 1860. № 11. P. 1138–1147. https://doi.org/10.1016/j.bbagrm.2017.08.010
- Zhang X., Shao X., Zhang R. et al. Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy // Clin. Epigenetics. 2021. V. 13. № 1. P. 3. https://doi.org/10.1186/s13148-020-00996-1
- Cheedipudi S.M., Matkovich S.J., Coarfa C. et al. Genomic reorganization of lamin-associated domains in cardiac myocytes is associated with differential gene expression and dna methylation in human dilated cardiomyopathy // Circ. Res. 2019. V. 124. № 8. P. 1198–1213. https://doi.org/10.1161/CIRCRESAHA.118.314177
- Zhao W., Qian Lu, Luo J. et al. Cardiac troponin I R193H mutant interacts with HDAC1 to repress phosphodiesterase 4D expression in cardiomyocytes // Genes Dis. 2020. V. 8. № 4. P. 569–579. https://doi.org/10.1016/j.gendis.2020.01.004
- Simple ClinVar [Electronic resource]. URL: https://simple-clinvar.broadinstitute.org/ Accessed 03.2022.
- Shah P.P., Lv W., Rhoades J.H. et al. Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and derepress alternative fate genes // Cell Stem Cell. 2021. V. 28. № 5. P. 938–954.e9. https://doi.org/10.1016/j.stem.2020.12.016
- Guénantin A.C., Jebeniani I., Leschik J. et al. Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy // J. Clin. Invest. 2021. V. 131. № 1. P. e136488. https://doi.org/10.1172/JCI136488
- Johnston J.R., Selgrade D.F., McNally E.M. Epigenetic reprogramming to prevent genetic cardiomyopathy // J. Clin. Invest. 2021. V. 131. № 1. P. e143684. https://doi.org/10.1172/JCI143684
- Koczor C.A., Lee E.K., Torres R.A. et al. Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis // Physiol. Genomics. 2013. V. 45. № 14. P. 597–605. https://doi.org/10.1152/physiolgenomics.00013.2013
- Pepin M.E., Ha C.M., Crossman D.K. et al. Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure // Lab. Invest. 2019. V. 99. № 3. P. 371–386. https://doi.org/10.1038/s41374-018-0104-x
- Zhao W., Wu X., Wang Z. et al. Epigenetic regulation of phosphodiesterase 4d in restrictive cardiomyopathy mice with cTnI mutations // Sci. China Life Sci. 2020. V. 63. № 4. P. 563–570. https://doi.org/10.1007/s11427-018-9463-9
- Liu C.F., Abnousi A., Bazeley P. et al. Global analysis of histone modifications and long-range chromatin interactions revealed the differential cistrome changes and novel transcriptional players in human dilated cardiomyopathy // J. Mol. Cell. Cardiol. 2020. V. 145. P. 30–42. https://doi.org/10.1016/j.yjmcc.2020.06.001
- Zhang W., Qu J., Liu G.H., Belmonte J.C.I. The ageing epigenome and its rejuvenation // Nat. Rev. Mol. Cell. Biol. 2020. V. 21. № 3. P. 137–150. https://doi.org/10.1038/s41580-019-0204-5
- Pal S., Tyler J.K. Epigenetics and aging // Sci. Adv. 2016. V. 2. № 7. P. e1600584. https://doi.org/10.1126/sciadv.1600584
- Yang B., Zhao H., Dong R. MiR-449 improves cardiac function by regulating HDAC1 and cTnI // Eur. Rev. Med. Pharmacol. Sci. 2020. V. 24. № 24. P. 12827–12835. https://doi.org/10.26355/eurrev_202012_24184
- Zhang C.L., McKinsey T.A., Chang S. et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy // Cell. 2002. V. 110. № 4. P. 479–488. https://doi.org/10.1016/s0092-8674(02)00861-9
- Han P., Hang C.T., Yang J., Chang C.P. Chromatin remodeling in cardiovascular development and physiology // Circ. Res. 2011. V. 108. № 3. P. 378–396. https://doi.org/10.1161/CIRCRESAHA.110.224287
- Hohl M., Wagner M., Reil J.C. et al. HDAC4 controls histone methylation in response to elevated cardiac load // J. Clin. Invest. 2013. V. 123. № 3. P. 1359–1370. https://doi.org/10.1172/JCI61084
- Theis J.L., Sharpe K.M., Matsumoto M.E. et al. Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy // Circ. Cardiovasc. Genet. 2011. V. 4. № 6. P. 585–594. https://doi.org/10.1161/CIRCGENETICS.111.961052
- Ai S., Peng Y., Li C. et al. EED orchestration of heart maturation through interaction with HDACs is H3K27me3-independent // Elife. 2017. V. 6. P. e24570. https://doi.org/10.7554/eLife.24570
- Kao Y.H., Liou J.P., Chung C.C. et al. Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure // Int. J. Cardiol. 2013. V. 168. № 4. P. 4178–4183. https://doi.org/10.1016/j.ijcard.2013.07.111
- Montgomery R.L., Davis C.A., Potthoff M.J. et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility // Genes Dev. 2007. V. 21. № 14. P. 1790–1802. https://doi.org/10.1101/gad.1563807
- Montgomery R.L., Potthoff M.J., Haberland M. et al. Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice // J. Clin. Invest. 2008. V. 118. № 11. P. 3588–3597. https://doi.org/10.1172/JCI35847
- Ito E., Miyagawa S., Fukushima S. et al. Histone modification is correlated with reverse left ventricular remodeling in nonischemic dilated cardiomyopathy // Ann. Thorac. Surg. 2017. V. 104. № 5. P. 1531–1539. https://doi.org/10.1016/j.athoracsur.2017.04.046
- Fan S., Zhang M.Q., Zhang X. Histone methylation marks play important roles in predicting the methylation status of CpG islands // Biochem. Biophys. Res. Commun. 2008. V. 374. № 3. P. 559–564. https://doi.org/10.1016/j.bbrc.2008.07.077
- Cedar H., Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms // Nat. Rev. Genet. 2009. V. 10. № 5. P. 295–304. https://doi.org/10.1038/nrg2540
- Glezeva N., Moran B., Collier P. et al. Targeted DNA methylation profiling of human cardiac tissue reveals novel epigenetic traits and gene deregulation across different heart failure patient subtypes // Circ. Heart. Fail. 2019. V. 12. № 3. P. e005765. https://doi.org/10.1161/CIRCHEARTFAILURE.118.00-5765
- Morival J.L.P., Widyastuti H.P., Nguyen C.H.H. et al. DNA methylation analysis reveals epimutation hotspots in patients with dilated cardiomyopathy-associated laminopathies // Clin. Epigenetics. 2021. V. 13. № 1. P. 139. https://doi.org/10.1186/s13148-021-01127-0
- Wu T.T., Ma Y.W., Zhang X. et al. Myocardial tissue-specific Dnmt1 knockout in rats protects against pathological injury induced by Adriamycin // Lab. Invest. 2020. V. 100. № 7. P. 974–985. https://doi.org/10.1038/s41374-020-0402-y
- Fang X., Robinson J., Wang-Hu J. et al. cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes // Am. J. Physiol. Cell. Physiol. 2015. V. 309. № 6. P. C425–C436. https://doi.org/10.1152/ajpcell.00058.2015
- Bain C.R., Ziemann M., Kaspi A. et al. DNA methylation patterns from peripheral blood separate coronary artery disease patients with and without heart failure // ESC Heart Fail. 2020. V. 7. № 5. P. 2468–2478. https://doi.org/10.1002/ehf2.12810
- Movassagh M., Choy M.K., Goddard M. et al. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure // PLoS One. 2010. V. 5. № 1. P. e8564. https://doi.org/10.1371/journal.pone.0008564
- Koczor C.A., Torres R.A., Fields E.J. et al. Thymidine kinase and mtDNA depletion in human cardiomyopathy: Epigenetic and translational evidence for energy starvation // Physiol. Genomics. 2013. V. 45. № 14. P. 590–596. https://doi.org/10.1152/physiolgenomics.00014.2013
- Haas J., Frese K.S., Park Y.J. et al. Alterations in cardiac DNA methylation in human dilated cardiomyopathy // EMBO Mol. Med. 2013. V. 5. № 3. P. 413–429. https://doi.org/10.1002/emmm.201201553
- Jo B.S., Koh I.U., Bae J.B. et al. Methylome analysis reveals alterations in DNA methylation in the regulatory regions of left ventricle development genes in human dilated cardiomyopathy // Genomics. 2016. V. 108. № 2. P. 84–92. https://doi.org/10.1016/j.ygeno.2016.07.001
- Jo B.S., Koh I.U., Bae J.B. et al. Data of methylome and transcriptome derived from human dilated cardiomyopathy // Data Brief. 2016. V. 9. P. 382–387. https://doi.org/10.1016/j.dib.2016.09.006
- Meder B., Haas J., Sedaghat-Hamedani F. et al. Epigenome-wide association study identifies cardiac gene patterning and a novel class of biomarkers for heart failure // Circulation. 2017. V. 136. № 16. P. 1528–1544. https://doi.org/10.1161/CIRCULATIONAHA.117.027355
- Li B., Feng Z.H., Sun H. et al. The blood genome-wide DNA methylation analysis reveals novel epigenetic changes in human heart failure // Eur. Rev. Med. Pharmacol. Sci. 2017. V. 21. № 8. P. 1828–1836.
- Ortega A., Tarazón E., Gil-Cayuela C. et al. ASB1 differential methylation in ischaemic cardiomyopathy: relationship with left ventricular performance in end-stage heart failure patients // ESC Heart Fail. 2018. V. 5. № 4. P. 732–737. https://doi.org/10.1002/ehf2.12289
- Gi W.T., Haas J., Sedaghat-Hamedani F. et al. Epigenetic regulation of alternative mRNA splicing in dilated cardiomyopathy // J. Clin. Med. 2020. V. 9. № 5. P. 1499. https://doi.org/10.3390/jcm9051499
- Watanabe T., Okada H., Kanamori H. et al. In situ nuclear DNA methylation in dilated cardiomyopathy: an endomyocardial biopsy study // ESC Heart Fail. 2020. V. 7. № 2. P. 493–502. https://doi.org/10.1002/ehf2.12593
- Haas J., Frese K.S., Sedaghat-Hamedani F. et al. Energy metabolites as biomarkers in ischemic and dilated cardiomyopathy // Int. J. Mol. Sci. 2021. V. 22. № 4. P. 1999. https://doi.org/10.3390/ijms22041999
- Liu L., Huang J., Liu Y. et al. Multiomics analysis of transcriptome, epigenome, and genome uncovers putative mechanisms for dilated cardiomyopathy // Biomed. Res. Int. 2021. V. 2021. P. 6653802. https://doi.org/10.1155/2021/6653802
- Tabish A.M., Arif M., Song T. et al. Association of intronic DNA methylation and hydroxymethylation alterations in the epigenetic etiology of dilated cardiomyopathy // Am. J. Physiol. Heart. Circ. Physiol. 2019. V. 317. № 1. P. H168–H180. https://doi.org/10.1152/ajpheart.00758.2018
- Zhang P., Li T., Liu Y.Q. et al. Contribution of DNA methylation in chronic stress-induced cardiac remodeling and arrhythmias in mice // FASEB J. 2019. V. 33. № 11. P. 12240–12252. https://doi.org/10.1096/fj.201900100R
- Mittal A., Sharma R., Prasad R. et al. Role of cardiac TBX20 in dilated cardiomyopathy // Mol. Cell. Biochem. 2016. V. 414. № 1–2. P. 129–136. https://doi.org/10.1007/s11010-016-2666-5
- Kmietczyk V., Riechert E., Kalinski L. et al. m6A-mRNA methylation regulates cardiac gene expression and cellular growth // Life Sci. Alliance. 2019. V. 2. № 2. P. e201800233. https://doi.org/10.26508/lsa.201800233
- Moore J.B. 4th, Zhao J., Keith M.C. et al. The epigenetic regulator HDAC1 modulates transcription of a core cardiogenic program in human cardiac mesenchymal stromal cells through a p53-dependent mechanism // Stem Cells. 2016. V. 34. № 12. P. 2916–2929. https://doi.org/10.1002/stem.2471
- Williams A.M., He W., Li Y. et al. Histone deacetylase inhibition attenuates cardiomyocyte hypoxia-reoxygenation injury // Curr. Mol. Med. 2018. V. 18. № 10. P. 711–718. https://doi.org/10.2174/1566524019666190208102729
- Jiang D.S., Yi X., Li R. et al. The histone methyltransferase mixed lineage leukemia (MLL) 3 may play a potential role on clinical dilated cardiomyopathy // Mol. Med. 2017. V. 23. P. 196–203. https://doi.org/10.2119/molmed.2017.00012
- Watson C.J., Horgan S., Neary R. et al. Epigenetic therapy for the treatment of hypertension-induced cardiac hypertrophy and fibrosis // J. Cardiovasc. Pharmacol. Ther. 2016. V. 21. № 1. P. 127–137. https://doi.org/10.1177/1074248415591698
- Pepin M.E., Drakos S., Ha C.M. et al. DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure // Am. J. Physiol. Heart Circ. Physiol. 2019. V. 317. № 4. P. H674–H684. https://doi.org/10.1152/ajpheart.00016.2019
- Horvath S. DNA methylation age of human tissues and cell types // Genome Biol. 2013. V. 14. № 10. P. R115. https://doi.org/10.1186/gb-2013-14-10-r115
- Кучер А.Н., Назаренко М.С., Марков А.В. и др. Вариабельность профилей метилирования CpG-сайтов генов микроРНК в лейкоцитах и тканях сосудов при атеросклерозе у человека // Биохимия. 2017. Т. 82. Вып. 6. С. 923–933.
- Forini F., Kusmic C., Nicolini G. et al. Triiodothyronine prevents cardiac ischemia/reperfusion mitochondrial impairment and cell loss by regulating miR30a/p53 axis // Endocrinology. 2014. V. 155. № 11. P. 4581–4590. https://doi.org/10.1210/en.2014-1106
- Mathiyalagan P., Okabe J., Chang L. et al. The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart // Nucl. Acids Res. 2014. V. 42. № 2. P. 790–803. https://doi.org/10.1093/nar/gkt896
- Harikrishnan K.N., Okabe J., Mathiyalagan P., Khan A.W. et al. Sex-based mhrt methylation chromatinizes MeCP2 in the heart // iScience. 2019. V. 17. P. 288–301. https://doi.org/10.1016/j.isci.2019.06.031
- Dal-Pra S., Hodgkinson C.P., Mirotsou M. et al. Demethylation of H3K27 is essential for the induction of direct cardiac reprogramming by miR combo // Circ. Res. 2017. V. 120. № 9. P. 1403–1413. https://doi.org/10.1161/CIRCRESAHA.116.308741